Nanophotonics for bacterial detection and antimicrobial susceptibility testing by Pitruzzello, Giampaolo et al.
This is a repository copy of Nanophotonics for bacterial detection and antimicrobial 
susceptibility testing.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/167692/
Version: Published Version
Article:
Pitruzzello, Giampaolo, Conteduca, Donato and Krauss, Thomas F. 
orcid.org/0000-0003-4367-6601 (2020) Nanophotonics for bacterial detection and 
antimicrobial susceptibility testing. Nanophotonics. ISSN 2192-8614 
https://doi.org/10.1515/nanoph-2020-0388
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Review
Giampaolo Pitruzzello*, Donato Conteduca and Thomas F. Krauss
Nanophotonics for bacterial detection and
antimicrobial susceptibility testing
https://doi.org/10.1515/nanoph-2020-0388
Received July 21, 2020; accepted August 27, 2020; published online
September 17, 2020
Abstract: Photonic biosensors are a major topic of research
that continues to make exciting advances. Technology has
now improved sufficiently for photonics to enter the realmof
microbiology and to allow for the detection of individual
bacteria. Here, we discuss the different nanophotonic mo-
dalities used in this context and highlight the opportunities
they offer for studying bacteria. We critically review exam-
ples from the recent literature, starting with an overview of
photonic devices for the detection of bacteria, followed by a
specific analysis of photonic antimicrobial susceptibility
tests. We show that the intrinsic advantage of matching the
optical probed volume to that of a single, or a few, bacterial
cell, affords improved sensitivity while providing additional
insight into single-cell properties. We illustrate our argu-
ment by comparing traditional culture-based methods,
which we term macroscopic, to microscopic free-space op-
tics and nanoscopic guided-wave optics techniques. Partic-
ular attention is devoted to this last class by discussing
structures such as photonic crystal cavities, plasmonic
nanostructures and interferometric configurations. These
structures and associated measurement modalities are
assessed in terms of limit of detection, response time and
ease of implementation. Existing challenges and issues yet
to be addressed will be examined and critically discussed.
Keywords: antimicrobial resistance; bacteria; evanescent-
wave sensing; photonic biosensors.
1 Introduction
Bacteria are ubiquitous in nature. Asmuch as they are vital
for our survival and the balance of any ecosystem, they can
also be harmful and pose serious risks in areas such as
health care, food, or environmental security [1–4]. Therefore,
the detection andmonitoring of bacteria are key challenges,
with time to result and sensitivity beingmajor drivers. This is
especially true in health care applications, where antimi-
crobial resistance (AMR) is a key issue and where the slow-
ness of current antimicrobial susceptibility tests (ASTs)
prevents timely and specific drug prescription [4–6].
Traditional microbiological techniques for detecting
and studying bacteria are culture-based, whereby bacteria
are grown on a substrate, such as an agar plate, for visual
inspection. These techniques are labour-intensive, time-
consuming, and difficult to conduct outside a specialized
microbiology laboratory. Another crucial limitation of
traditional tests is that they examine billions of microor-
ganisms at once, thereby washing out cellular in-
dividuality and heterogeneity; the outcome is a single
value within a confidence interval, which then disregards
any underlying distribution of quantities of interest. Bac-
terial populations, however, are strongly heterogeneous
and cell-to-cell differences are crucial in a variety of phe-
nomena, such as the development of antibiotic hetero-
resistance [7–9] or persistence [7, 10]. In addition, there is
growing evidence that the heterogeneity of bacterial col-
onies is a key factor in determining the failure of an anti-
biotic therapy [11, 12]. Consequently, an ideal AST must be
able to discern the signature(s) of susceptibility to the
antibiotic at low concentrations of bacteria by character-
izing their response at the single bacteria level, with the
twofold aim of speeding up detection and probing the
heterogeneity of the bacterial population [13–15]. Novel
optical and photonic detection modalities have recently
emerged to address this challenge. Photonic sensors
exploit the interaction of guided light with bacteria to
detect their presence and probe their response, whereby
the use of light offers key advantages, such as immunity to
external electromagnetic interferences that may disturb
sensors operating in other regions of the electromagnetic
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spectrum [16], and ease of parallel, high-sensitivity and
noncontact detection.
Optical sensors can be divided into fluorescence-based
and label-free devices. To date, most light-based sensors
use fluorescence, whereby target molecules, such as those
on the bacterial cell wall, are labelled with fluorophores to
indicate the presence, concentration and activity of bac-
teria [17]. While a comprehensive comparison between
fluorescence-based and label-free sensors is beyond the
scope of this article, we note that the former is extremely
sensitive, selective and easily able to reach singe-cell res-
olution. On the other hand, fluorescent labelling compli-
cates procedures, can interfere with bacterial viability and
requires prior knowledge of the bacteria to be labelled [18,
19]. We therefore focus on label-free techniques. In addi-
tion, biosensors can be divided into two further groups:
those detecting target bacterial components, such as ge-
netic material or specific enzymes and those based on
whole cell detection [2]. The former class requires further
sample processing to extract and purify the targetmaterial,
such as cell lysis, which inevitably increases process time
and complexity. Hence here, in the interest of simplicity,
we focus on label-free whole-bacteria detection techniques
that guide, confine or mould light with nanostructures.
1.1 The role and advantages of photonic in
bacterial detection and ASTs
Photonic sensors achieve their functionality by exploiting
enhanced light-matter interaction, tightmode confinement
and extreme phase sensitivity. Photonic sensors are typi-
cally based on guided modes and interact with the analyte
via their evanescent tail. The overlap integral (OI) quan-
tifies the fraction of themode’s electric field intensity |E(r)|2
overlapping with the cladding material to be sensed and
can be expressed as
OI   
∫
Vclad
ε(r)|E(r)|2d
3
r
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ε(r)|E(r)|2d
3
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The integration is carried out over the cladding volume
above the sensor surface (Vclad) and the total volume of the
mode (Vtot), while ε(r) represents the spatial dependency
of the dielectric constant. This integral is therefore a key
determinant of the bulk sensitivity of the method. Larger
values of the OI correspond to a larger overlap of the field
with the sensing medium leading, in turn, to a bigger
change of the effective index of the mode for a given
change of the refractive index of the cladding. All sensors
based on surface plasmons and those based on dielectric
waveguides are based on this principle.
The extent of the evanescent tail determines the
interaction volume, and is easily obtained from guided-
mode theory via the decay constant γ:
γ   
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
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where neff is the effective index of the opticalmode, nc is the
refractive index of the cladding (typically water, i.e. nc ∼
1.33) and λ the wavelength. Considering that the effective
index is 1.5–1.7 for a plasmonic mode and 1.5–2.5 for a
dielectricmode, the typical decay length 1/γ inwater-based
claddings is in the range of 100–200 nm [20].
These values of γ imply that because the interaction
with surface-attached bacteria only occurs via the
evanescent tail of themode, the probed volume is limited to
the bacterial membrane and its immediate vicinity inside
the cell. The limited penetration of the optical mode also
means that background interference, for example, from
bacteria and media further away from the surface, is
minimized, making for good signal to noise ratios. There-
fore, photonic structures naturally offer themselves as
good candidates for the sensing of single or small numbers
of bacteria.
In addition, such a localized interaction makes nano-
photonic structures able to probe different bacterial prop-
erties. For example, different bacterial strains have
different optical density (OD) of the cell wall, therefore
enabling identification [21, 22]; the OD of the membrane
may change as a result of an antibiotic challenge which
manifests itself as a change in refractive index [23]; the
motion of bacteria is an indicator for their metabolic ac-
tivity and is manifested as readout noise [24, 25]; the
morphology of the cell may be affected by antibiotics and
will impact on its light scattering properties [26]. In any of
these cases, the increased sensitivity offered by nano-
photonic structures can allow for individual bacteria to be
detected and analysed.
It is important to note that because bacteria need to be
exposed to the evanescent tail of the confined mode to be
detected and analysed, the sensor surface is often coated
with biorecognition elements, such as antibodies, aptamers
or bacteriophages that selectively bind to proteins in the
bacterial membrane [27]. In addition, optical biosensors
often rely on microfluidic methods to deliver the analyte to
the sensing area [28]. The use of microfluidics comes with
the attractive advantage of reducing the required volume of
solution while decreasing the characteristic length and
diffusion time needed for bacteria to reach and attach to the
sensor’s surface [29, 30]. While a thorough description of
these aspects is outside the scopeof this review,wenote that
both the surface chemistry and the microfluidics are key
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factors in determining the overall performance of a sensor.
This is especially true for the detection time, which depends
on the dimension of the respective fluidic cell, as surface
affinity binding is fundamentally driven by diffusion, but
also the quality of the surface receptor layers and the
binding affinity to the bacteria of interest.
Even though the recent literature is rich with examples
of photonic biosensing platforms, we believe that the po-
tential of photonics in this space has not yet been fully
exploited. To this end, we wish to present some of the most
relevant recent work to provide a critical assessment of the
state of the art and to highlight the key advantages of
photonic techniques for the detection and study of single
bacteria, especially in the context of AMR.
The review is divided into twomajor sections. In Section
2, we discuss different methods for detecting and imaging
bacteria, mainly focussing on evanescent wave nano-
photonic sensors. Section 3 describes the different photonic
methods used for studying the susceptibility of bacteria to
antibiotics. To highlight the benefits of light confinement,
we discuss techniques in order of progressive reduction of
the optically probed volume. We start with traditional
culture-based methods, such as the disk diffusion test,
which we term macroscopic, then move on to microscopic
free-space optical and nanoscopic guided-wave optical
methods. While macroscopic techniques are based on
averaging cellular growth over the entire bacterial popula-
tion, microscopic free-space optics methods such as bulk
optical tweezers, elastic light scattering, flow cytometry and
some nanostructure-based techniques afford probing fewer
bacteria, even down to single cells, but still retrieve infor-
mation from the entire cell. Conversely, nanoscopic tech-
niques such as surface plasmon resonances (SPRs), guided
mode resonances (GMRs) or metasurfaces-based configu-
rations rely on guided-wave optics and exploit the evanes-
cent wave at interfaces, as described previously. The optical
field is now confined to the surface of the sensor so that only
the bacterial membrane is probed. Some of the nanoscopic
techniques also exploit resonant enhancement which
further increases sensitivity [21, 23, 31, 32]. Overall, we show
that this reduction in volumeenables gaining further insight
into bacterial behaviour, as well as increasing sensitivity
and reducing the time needed to assess antibiotic action.
2 Photonics for bacterial detection
In terms of detection and observation, macroscopic and
microscopic techniques require little introduction; the first
bacteria were observed with a microscope by van Leeu-
wenhoek in 1677 [33]. We therefore move straight to
nanophotonic techniques used to detect and image bac-
teria at very low concentrations, down to the single cell
level. We classify the structures into two main categories:
plasmonic and dielectric (See Tables 1 and 2), and we
discuss them with particular attention to the optically
probed volume relative to the volume of a single bacterial
cell. We also discuss the current limitations of nano-
photonics for bacterial studies to highlight potential future
research directions.
2.1 Plasmonic configurations
2.1.1 SPR devices
Plasmonic biosensors typically consist of metallic thin films
which support SPRs and which strongly confine light at the
interface between the thinmetal film and the analyte. Using
surface functionalization techniques, the metal layer then
allows to selectively bind biomarkers or cells of interest.
SPRs are typically excited using the Kretschmann configu-
ration, whereby light is injected through a prism and any
changes in refractive index result in a change of resonance
angle, wavelength, or intensity. SPR was the first label-free
photonic detection technique to be commercialized (by
Biacore, now GE Healthcare).
More recently, SPR sensors have also been used for the
detection and imaging of bacteria. SPR offers a particularly
high surface sensitivity, both because of the strong overlap
of the evanescent field with the analyte and because of its
peculiar mode coupling properties [34, 35], which allows
for the detection of very low concentrations of bacteria,
that is, down to 102–103 CFU/mL (colony-forming units) in
t∼ 20min [36]. It is important to note that the detection time
is not limited by the detection principle, but it depends on
other factors such as the surface functionalization protocol
and is influenced by the quality of the bioreceptor layer and
its binding affinity to the target bacterium.
Several sensing techniques have been used to further
improve the sensitivity of plasmonic configurations, for
example, by imprinting bacteria in soft polymers on metal
slabs or by using metal nanoparticles to enhance the
changes of reflectivity on bacterial binding [37]. However,
even if these sensing schemes provide an Limit Of Detec-
tion (LOD) < 1 CFU/mL, their main issue is the need for a
rather complex and slow preparation process (>24 h),
which makes them less ideal for rapid diagnosis and
commercialization, therefore impacting on the attractive-
ness of the approach.
A simpler SPR measurement scheme is offered by
crossed surface relief gratings (CSRGs), which consist of
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two orthogonally superimposed dielectric gratings covered
by a thin metal layer. One of the gratings provides the
necessary wavevector to excite the plasmon wave if the
incident field is polarized along the grating vector. Energy
is then exchanged between the two gratings, such that light
is radiated by the second grating with a polarization
orthogonal to the incident one. Therefore, if the CSRG is
placed between two cross polarizers and illuminated by
broadband light, a peak in the transmission spectrum
is observed and used for biosensing. This principle
enabled to simplify the optical setup compared to tradi-
tional SPR, even though more modest LODs were achieved
(<105 CFU/mL for Escherichia coli) [38].
2.1.2 Plasmonic nanohole arrays
An alternative way of exciting surface plasmons is to use
grating-coupling instead of the prism-coupling method
used in the Kretschmann configuration. The grating-
coupling method is best embodied by the nanohole array
(NHA) geometry, that is, a periodic distribution of sub-
wavelength apertures [39]. These subwavelength apertures
both enable easy out-of-planecouplingand they support the
phenomenon of enhanced optical transmission at reso-
nance which leads to a significant energy enhancement in
the nanoapertures [40]. The ease of light-coupling and the
compatibility with cost-effective optical components (e.g.
LED sources) also makes for an easy implementation.
Although the bulk sensitivity of plasmonic nanostructures is
typically lower than that of prism-coupled SPR sensors [34,
35], the strong light confinement in the nanoapertures im-
proves surface sensitivity and spatial resolution. These
features have been shown to be beneficial to biochemical
sensing, whereby plasmonic nanoholes have achieved low
limits of detection for proteins. More recently, applications
in bacterial detection have also emerged [31, 41, 42].
For example, Gomez-Cruz et al. [42] demonstrated the
detection of low concentrations of uropathogenic E. coli in
urine by using a plasmonic nanohole array with intensity-
based measurements in only 15 min. The sensor exhibits an
LOD of 100 CFU/mL, which is comparable with other plas-
monic techniques [36]. Notably, the authors achieved
detection with an analyte volume as small as 10 μL, which
means that, on average, only a single bacteriumwas present
and detected. A similar performance was achieved by Dey
et al. with an NHA configuration combined with an inter-
ferometric approach [31] where the interference between
two spatially separated, orthogonally polarized beams was
measured. Measuring the relative difference between two
collinear beams, rather than the absolute change of an in-
dividual one, minimizes the impact of mechanical, thermal,
and optical source noise, which we have recently shown to
be advantageous also for protein measurements [43].
In the context of this review, we note that the afore-
mentioned interferometric approach enabled the detection
of a single E. coli bacterium in a volume of 10 μL of
diluted blood plasma [31]. This corresponds to an
LOD = 100 CFU/mL, which is the same as that achieved
with the intensity-based sensor by Gomez-Cruz et al.
mentioned previously [42]. Nevertheless, it is important
to note that the interferometric device was realized in a
handheld format, where the noise level is typically higher
than in an optical benchtop experiment. The higher
sensitivity of interferometry therefore compensates for
the higher noise, which has led to the detection of a single
bacterium with a portable instrument and represents a
notable proof of concept for the translation of a nano-
plasmonic device into the medical environment.
2.1.3 Plasmonic imaging
SPR sensors have been also used for the imaging of bio-
logical samples, such as cells and bacteria. This prism-
based SPR imaging (SPRi) method exploits both the
angular and thewavelength response of a fixed input beam
to generate the image and the sensing information [44].
Using thismethod, Bouguelia et al. [45] have demonstrated
the detection of less than 20 CFU/mL of E. coliwith a prism-
based SPRi system. However, a limitation of prism-based
SPRi is that the image plane is not perpendicular to the
optical axis of the system, which creates a skew between
the camera and the sensor surface. Only a narrowband is in
focus in the image with a consequent worsening of reso-
lution [46, 47], which severely limits the field of view.
A solution to the skew issue was introduced by Bou-
lade et al. [46], who developed a resolution-optimized
surface plasmon resonance imaging (RO-SPRi). The
method consists of capturing multiple images in different
focal planes to overcome the skew between the camera
image plane and the sensor surface. The RO-SPRi system
enabled imaging of individual Listeria monocytogenes and
Listeria innocua bacteria and made them clearly visible
with a field of view of 1.5 mm2. In a direct comparison with
differential interference contrast microscopy, they also
showed that, not only SPRi managed to achieve a compa-
rable field of view, but it also provided a higher accuracy in
picking out bacteria on the sensor surface because it is
based on evanescent fields rather than on Gaussian beams.
This higher accuracy only refers to the vertical axis,
however. In the lateral dimension, the resolution is limited
by the propagation length of the plasmon wave, which is
typically of order 5–10 μm, so larger than the dimension of
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a typical bacterium. Nevertheless, by using relatively short
wavelengths (e.g. 530 nm) or lossy substrates (e.g.
aluminium) [48, 49], the propagation length can be
reduced significantly. A different strategy for improving
the lateral resolution consists of using an objective-based
SPRi [50], whereby the need for the prism typical of the
traditional Kretschmann configuration is eliminated by
launching the SPR through a high numerical aperture (NA)
immersion objective. Eliminating the physical constraints of
the prism allows for higher NA and magnification to be
achieved and, therefore, for spatial resolution to be
increased. Indeed, this technique enabled the imaging of
individual E. coli [51], of single influenza viruses [52], the
mapping ofproteinswithinmammalian cellmembranes [53]
and the tracking of organelles within a cell body [54]. These
results confirm the suitability of SPRi for the nanoscopic
analysis of bacteria and viruses as long as the limitations of
the technique are understood and suitably addressed.
As an alternative, CSRGs have also been used for the
SPRi of bacteria. Even though the resonant information
was not in resolved spatially, Nair et al. obtained an LOD of
100 CFU/mL for E. coli by measuring the intensity changes
induced by bacterial binding onto CSRGs [55].
2.1.4 Plasmonic nanotweezers
Plasmonic nanostructures have also been used to trap
bacteria using optical forces. The pioneering studies of
Ashkin et al. [56, 57] already demonstrated the contact-free
trapping of single E. coli bacteria with a laser beam.
Nevertheless, trapping required optical powers of tens of
milliwatts, which rendered the bacteria inviable after only
a few minutes because of photodamage [56]. The issue of
photodamage can be overcome by resorting to near-field
techniques that offer a stronger field gradient, which leads
to stronger trapping forces even at low power. In fact, the
trapping action is directly proportional to the gradient
force, and therefore proportional to the gradient of the
electric field, while the scattering and the absorption forces
are proportional to the light intensity. As a result, nano-
scale confinement affords strong trapping forces because
of the strong gradient field generated in the near-field even
with limited input power while limiting the contributions
of scattering and absorption [58].
The trapping of bacteria in the near-field was then
demonstrated by Lotan et al. [59] who fabricated nanoscale
plasmonic V-groove waveguides as shown in Figure 1(a).
The modes of these waveguides exert strong optical forces
on objects in their proximity, which was verified by col-
lecting the fluorescence signal from labelled bacteria (see
Figure 1(b) and (c)). Even more impressively, trapping of
single proteins was demonstrated with a gold double-
nanohole structure [60], which confirms the suitability of
near-field techniques for the trapping of nanoscale objects,
given that optical forces scale with the volume of the object
[58].
Exploiting resonant enhancement, plasmonic nano-
structures have been used by Righini et al. [61], who ach-
ieved the trapping of several individual bacteria
simultaneously in an array of dipole nanoantennas (see
schematic in Figure 1(d)). Stable confinement with a trap-
ping time of several hours was observed with a power
density of about 108 W/m2, or 0.1 mW/μm2. This value is
almost two orders of magnitude lower than SPR-based
plasmonic tweezers and much lower than the damage
threshold values for bacteria, which is typically quoted as
1010 W/m2, or 10 mW/μm2 [62, 63]. Examples of trapped
bacteria are shown in Figure 1(f). This achievement clearly
highlights the benefits of resonant enhancement and near-
field trapping and confirm the advantages offered by
nanostructured tweezers for the detection and manipula-
tion of individual bacteria. In addition, thanks to the
arraying capability of several individual cells over time,
these nanotweezers may enable further studies of the time-
dependence of the bacterial response to drugs, which will
be further discussed in Section 3.
2.2 Dielectric configurations
Dielectric configurations have been investigated more
recently with a view to overcoming the limitations arising
from the intrinsic optical losses of plasmonic systems [20,
64, 65]. Dielectric materials are typically transparent in the
visible and near-IR range, thereby minimizing absorption
and reducing thermal effects due to Joule heating. Similar
to their plasmonic counterpart, dielectric structures are
refractive index sensors that interact with the analyte via
the evanescent tail of the mode they support, meaning that
they may also enable probing the bacteria nanoscopically.
However, unlike plasmonic devices, dielectric structures
can support resonances with higher dynamic range,
because of the lower loss, which improves the signal-to-
noise ratio and, in principle, makes it easier to detect small
objects such as bacteria.
2.2.1 Optical waveguides and interferometric
approaches
Sensors based on optical waveguides were the first
dielectric configurations to be used for bacterial detection
[66]. These waveguides detect the phase change incurred
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by a bacterium attaching to the surface, which is most
sensitively realized via an interferometric readout. The first
Mach–Zehnder interferometers were used to detect
L. monocytogenes with a sensitivity of 105 CFU/mL [67].
Several improvements have since beenmade. For example,
Maldonado et al. [68, 69] have demonstrated a bimodal
waveguide for the detection of low concentrations of bac-
teria, that is, down to 40 CFU/mL. The device consists of
an optical waveguide in Si3N4 supporting two modes
with different polarization, as schematically shown in
Figure 2(a). The advantage of this bimodal waveguide
approach is that environmental fluctuations, especially
temperature, affect both modes almost equally, which al-
lows to improve the signal-to-noise ratio. A schematic and
data taken with this technique are shown in Figure 2(b).
From a practical point of view, a limitation of the op-
tical waveguide-based approach is the need to launch light
into the waveguide, which requires rather demanding
coupling arrangements and makes these devices not
compatible with standard microscopes. As an alternative,
the interferometer can be realized in an optical fibre, for
which standardized coupling interfaces exist [70, 71]. The
interferometer can be made of two identical chirped long
period gratings (CLPGs) as illustrated in Figure 2(c). The
first CLPG partially couples the light from the core mode to
the cladding mode. Both modes propagate through the
sensing area, where the fibre cladding is open and func-
tionalized to detect attached bacteria. At the second CLPG,
the cladding mode is coupled back into the fibre core,
therefore interfering with the core mode. Because only the
cladding mode interacts with the bacteria, their presence
provides the phase shift and resulting interference signal.
Figure 2(d) and (e) show how different concentrations of
E. coli impact on the optical transmission spectra of the
fibre. An LOD of only 7 CFU/mL of E. coliwas reported [72],
which highlights the remarkable sensitivity of this
technique.
The major downside is that the tapered fibre is very
fragile, which can lead to easy breakage. However, recent
progress in judicious packaging has enabled nano-
structured fibres to be used directly in tissue for the
detection of cancer biomarkers [73] or in ready-to-eat meat
for the detection of pathogenic bacteria [74]. These results
highlight the importance of fibre sensors and demonstrate
the opportunity for the in vivo detection of bacteria. Finally,
it is interesting to note that interferometric waveguide
sensors, which are extremely sensitive for protein sensing,
do not perform as well as resonant ones for the detection of
individual bacteria. The reason lies in theirmodus operandi
because an interferometric sensor derives its sensitivity
from the long interaction length and the assumption that
the sensing arm is uniformly covered by the measurand.
Even though low concentrations of bacteria have been
detected, an interferometric waveguide does not allow for
bacteria localization. Therefore, if the goal is to monitor
individual or small numbers of bacteria, then the long
interaction length offers no advantage and a resonant
modality is preferable. This modality is discussed in the
next section.
2.2.2 Resonant metasurfaces
Resonant metasurfaces use nanostructures to create
distributed resonances for specific wavelengths
Figure 1: (a) Scanning Electron Microscope
(SEM) micrograph of bacteria attached to a
V-groove waveguide. (b, c) Fluorescence
excitation and emission of bacterial guided
in the groove [59]. (d) Schematic of a nano-
antenna on a glass substrate and SEM
micrograph of a single nanoantenna in the
inset (scale bar: 200 nm). (e) Two-photon
induced luminescence (TPL) from a single
nanoantenna for both longitudinal and
transversal polarization. (f) Optical trapping
of two individual Escherichia coli bacteria
on separate nanoantennas [61].
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determined by their period, thickness and/or fill-factor.
These resonant structures sample the bacterium multiple
times, so they can be understood as multipass devices,
whereas interferometric waveguides are single-pass de-
vices. The multipass nature of the resonant structure pro-
vides high sensitivity, while also affording out-of-plane
coupling, which simplifies optical characterization.
Despite the resonant enhancement and simplicity of
optical interrogation, initial reports did not achieve the
sensing or imaging of single cells. In fact, most of these
sensors have been limited to the quantification of bacterial
concentrations, with typical LODs of ∼200 CFU/mL ob-
tained for Legionella neumophila with a polymer 2D PhC
[75]. Different approaches have been used to improve res-
olution. In particular, the combination of 2D photonic
crystals (PhCs) with hydrogels [76, 77] has improved the
resolution down to 32 CFU/mL of E. coli [77], although a
number of complex preparation steps are required to ach-
ieve this result. An alternativeway to improve the LOD is by
using the field enhancement offered by PhCs to enhance
fluorescence. For instance, a polymeric 2D PhCwas used to
detect the fluorescence of resorufin, a compound often
used as a proxy of bacterial presence and viability. Even
though this method is not label-free, an LOD of 10 CFU/mL
of E. coli was demonstrated in wash water [78].
More recently, we have introduced a label-free resonant
metasurface based on a nanohole array in amorphous sili-
con (a:Si) that exhibits Fano resonances with a dynamic
range fromnear0%tonear 100%reflectionandaQ-factor of
300–400 [32]. Surprisingly, these high-Q resonances also
Figure 2: (a) Schematic of the dielectric bimodal waveguide (BiMW) (left) and (b) measured phase change versus Escherichia coli
concentration [68]. (c) Schematic of the cascaded chirped long period grating inscribed in the fibre core with (d) corresponding transmission
spectra for different concentrations of E. coli. (e) Wavelength shift of the functionalised (red line) and bare (black line) sensor with exposed to
E. coli concentrations from 10 to 60 CFU/mL [70].
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exhibit a very high spatial resolution, that is of order 1 μmor
better, whenused for hyperspectral imaging. This capability
is illustrated in Figure 3, where we use the combination of
strong localization, highQ factor and high dynamic range of
the optical mode to provide a quantitative analysis of the
refractive index distribution and imaging of a single E. coli
cell. These results clearly demonstrate that the metasurface
approach can be used for nanoscopic analysis because the
refractive index being probed is that of the bacterial mem-
brane. This ability could open up a variety of studies
including, for example, cell adhesion and secretion moni-
toring that have previously only been demonstrated with
mammalian cells [79, 80], but have never been applied to
bacteria. Monitoring the response of bacteria to antibiotic
challenge is another promising area of research opened up
by these structures, which is discussed in more detail in
Section 3.
2.2.3 Dielectric nanotweezers
Dielectric nanotweezers are of particular interest because
they can enhance near-field forces while minimizing the
thermal effects typical of plasmonic configurations because
thermal effects have been shown to be detrimental to trap-
ping stability [81, 82]. For example, the trapping of DNA
molecules was demonstrated in a slotted waveguide [83]
and nanotweezers based on dielectric waveguides are
already available commercially as portable instruments
(OPTOFLUIDICS, Inc). The main limitation of nanophotonic
waveguides is their lowerfield enhancement comparedwith
metallic nanostructures, which means that typically higher
powers are required to achieve trapping. However, the
trapping of bacteria is somewhat easier because of their
volume, and the optical manipulation of bacteria with sili-
con waveguides has been successfully demonstrated with
relatively low power (100 mW source power, corresponding
to a few milliwatts coupled into the waveguides) [84].
An interesting configuration has been recently pro-
posed by Zhao et al. [85], who fabricated waveguide pairs
separated by gaps of 200 nm. The small gap allows light to
be coupled laterally back and forth between the two
waveguides, therefore creating numerous trapping spots
and effectively generating an optical lattice. By using a
guided power of 3 mW, the authors managed to trap and
align individual Shigella at a rate of 12 bacteria/min and
conduct single-cell viability studies on exposure of the
trapped bacteria to ethanol.
Moving from one-dimensional confinement in wave-
guides to two-dimensional confinement in cavities allows
increasing the resonant enhancement further. The stronger
light-matter interaction provided by a two-dimensional
resonator leads to higher optical forces and therefore a
reduction in the input power needed. In addition, the self-
induced back-action mechanism can be exploited, which
enhances the restoring force that draws the bacteriumback
into the trapping site when it tries to escape. This mecha-
nism is the main reason for the stable trapping that has
been achievedwith very low optical power, that is orders of
magnitude lower than the power needed for conventional
bulk trapping [86]. For example, van Leest and Caro [87]
achieved stable trapping of individual bacteria with PhC
cavities requiring only 400 μW for both Gram-negative
(E. coli) and Gram-positive (Bacillus subtilis) bacteria.
Other examples include photonic crystal nanobeam
cavity and hollow PhC configurations [21, 22] that have
shown not only to trap, but also to analyse single bacteria
on chip. In particular, the stable trapping of individual
E. coli, Staphylococcus epidermidis diplococcus and B. sub-
tilis was observed using only hundreds of microwatts of
(estimated) power in the cavity. Both types of cavities
allowed distinguishing bacteria by size, shape andmotility
patterns via the magnitude of the observed change in the
transmission spectrum of the cavity and the noise of the
transmission trace. A further improvement was achieved
with the 2D side-coupled PhC cavity shown in Figure 4(a),
whereby a statistical analysis of the transmitted optical
power enabled the authors to correctly differentiate be-
tween Gram-positive and Gram-negative bacteria within a
Figure 3: (a) Scanning Electron Microscope
(SEM) image of the dielectric nanohole
array and simulated electric field at
resonance in the inset. (b) Brightfield
microscope versus hyperspectral images
of an individual Escherichia coli obtained
with a dielectric nanohole array [32].
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few seconds [22]. Typical histograms of the relative trans-
mission are shown in Figure 4(b).
Being able to extract so much information is clearly
enabled by the strong overlap of the bacterial cell wall with
the evanescent field of the cavity mode. In fact, Therisod
et al. [22] were able to use the histograms in Figure 4(b) to
explain the intrinsic heterogeneity of the bacterial pheno-
type as well as the differences in the composition of the
bacterial membrane of different species. For instance, the
authors noted that Gram-negative bacteria consistently
induced a larger change in transmission compared with
Gram-positive species. This observation correlates well
with the larger deformability of the cell wall of Gram-
negative species, as well as with the presence of lipo-
polysaccharides molecules exclusive to the cell wall of
Gram-negative bacteria. Importantly, the size of the bac-
teria is not the main discriminator in Figure 4(b) because
the length of both Gram-stain bacteria ranges between 0.5
and 4 μm.
From the aforementioned, it is clear that optical trap-
ping can provide significant information on the
morphology and themotility of bacteria. Recently, we have
proposed to add another dimension to this toolkit by
investigating the possibility of conducting electrical
impedance measurements on optically trapped bacteria.
The idea builds on the “electrophotonics” principle we
introduced earlier, whereby the judicious doping of silicon
allows conducting electrochemical measurements on the
surface of an optical waveguide structure in a high-Q sili-
con microring resonator [88, 89]. Using similar principles,
we considered an arrangement that combines silicon
photonic crystal cavities for optical trapping with doped
regions for conducting impedance measurements [90]. A
schematic of a single trap is shown in Figure 4(c). The idea
is tomonitor changes inmorphology andmotility optically,
as previously mentioned, together with changes in
impedance as the trapped bacterium is challenged by
various antibiotics (Figure 4(d)). We expect that such a
multiparametric approach will provide a more accurate
and potentially faster susceptibility analysis [25], while
placing multiple such nanotweezers into an array allows
probingmultiple bacteria in parallel and can therefore also
provide information on population heterogeneity.
An alternative waveguide geometry is to use an optical
fibre for trapping. This is clearly not nanoscopic, as the
fibre achieves trapping through a focussed Gaussian beam
created by tapering or lens-ending the fibre but is much
more versatile than a focussed beam created by a micro-
scope lens. For example, Xin et al. [91] demonstrated the
trapping of a single E. coli by fabricating a nano-tip on the
end of a single-mode fibre. The fibre is also tapered to focus
the light away from the tip while creating a sufficiently
strong energy confinement (Figure 4(e)) to ensure that the
bacterium is localized in all three dimensions. Examples of
a trapped E. coli are shown in Figure 4(f). This approach
offers interesting opportunities for bacterial studies as it
enables probing bacterial motility and dynamics in
different environments, possibly even in vivo.
However, themain limitation of fibre-based tweezers is
their weak optical gradient compared to integrated nano-
tweezers, which means that higher optical powers are
required to achieve stable trapping. For example, a power
of about 50 mW, corresponding to a power density of
∼1010 W/m2 (or 50 mW/μm2), was needed to trap a single
E. coli bacterium in the experiments by Xin et al. [91]. The
experiment only achieved stable trapping for approxi-
mately 2 min, whereas many studies require longer
observation times (Table 2). Amore stable trapmay require
higher power, which may then become phototoxic [63].
3 Photonic techniques for
antimicrobial susceptibility
testing
To help appreciate the advantages of photonic techniques
for susceptibility testing (AST), we start by briefly intro-
ducing the traditional microbiological ASTs, which belong
to the macroscopic category of techniques. We then move
onto microscopic free-space optics techniques which
afford measuring fewer bacteria, but still probe whole
cells. Finally, we discuss nanoscopic devices based on
guided-wave optics which limit light-matter interaction to
the bacterial membrane. We also briefly describe some
light-based instruments that have already been success-
fully commercialized. Throughout this entire section, it is
important to remember that ASTs begin with an isolation
step, which serves to isolate the bacteria of interest from a
complex biological sample, such as urine or blood. This
procedure requires culturing and, therefore, at least an
overnight incubation on agar plates [93, 94]. After the
isolate is obtained, the actual AST is carried out by
exposing bacteria to certain antibiotics. In this respect, all
the times to result mentioned in this section (and reported
as “drug test time” in Table 3) only refer to the drug testing
procedure, asmost of the current ASTs techniques require a
pure bacterial isolate as a starting point [4, 95].
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3.1 Traditional microbiological techniques
The traditional method for assessing antibiotic suscepti-
bility is the disk diffusion test developed in the 60s by
Bauer and Kirby [96], a schematic of which is shown in
Figure 5(a). On overnight incubation of bacteria on an agar
plate, the size of the clear rings surrounding antibiotic-
impregnated filter-paper disks are used to inform antibiotic
efficacy in stopping bacterial growth. Although this tech-
nique is easy to perform and inexpensive, it suffers from
slowness (24–48 h) and from being only semi-quantitative,
so that the lowest concentration of antibiotic that inhibits
bacterial growth (the minimum inhibitory concentration,
MIC) can usually not be determined.
A more robust solution is provided by microdilution
assays [97], whereby bacterial inoculums are added to
micro-wells and incubated overnight with two-fold di-
lutions of antibiotics, as shown in Figure 5(b). Bacterial
growth is then quantified by measuring the OD of the
suspension. A clear suspension corresponds to a low OD
Figure 4: (a) Illustration of the 2D PhC hollow cavity and Scanning Electron Microscope (SEM) image used for trapping individual Escherichia
coli by Therisod et al. [22]. (b) Histograms of the relative transmission measured for seven different bacteria. (c) Schematic of an
electrophotonic trap simulated by Conteduca et al. [90]. (d) Optical and electrical detection principles of individual bacteria. (e) Schematic of
the lensed fibre for contactless trapping of individual E. coli. (f) Trapping of individual E. coli achieved with the nanostructured fibre [91].
4456 G. Pitruzzello et al.: Nanophotonics for bacteria
and is indicative of little or no growth, hence antibiotic
effectiveness, as shown schematically in Figure 1(c).
Although these techniques are commonly used in clinical
settings and microbiology laboratories, they have a long
turnaround time because of the need for overnight incu-
bation. In addition, they require specialized personnel
because of the labour-intensive procedures of plating,
diluting reagents and preparing trays.
3.2 Commercial devices
The problemof ease of operation has been partly addressed
by commercial instruments, such as VITEK2 [98] (Bio-
Mérieux), MicroScan WalkAway [99] (Siemens Healthcare
Diagnostic) or BD Phoenix [100, 101] (BD Diagnostics).
Most of these instruments are based on a photonic readout
of OD or fluorescence of bacterial cultures in microwells as
indicators of bacterial growth and/or metabolism in the
presence of antibiotics.
These instruments introduced desirable features such
as automation of sample loading and processing as well as
a multiplexing capability; the VITEK2, for example, can
perform up to 240 tests simultaneously. In terms of time to
result, these instruments are capable of generating results
in 3.5–16 h (see Table 3), thereby representing some
improvement compared with the more traditional tech-
niques [98, 102, 103]. The improvement is limited, however,
because the detection is fundamentally culture-based.
Furthermore, these techniques also neglect heterogeneity
by averaging over the entire bacterial population. Finally,
it is important to note that significant discrepancies be-
tween the results obtained with these instruments, and
with the traditional methods have been reported. For these
reasons, it is difficult to define a true “gold standard” for a
susceptibility test [104–107].
Table : State of the art of nanophotonic sensors for bacteria detection and imaging.
Configuration Application Resolutiona Solution Timeb Reference
SPR with polymeric film Detection . CFU/mL E. coli Buffer  min []
Plasmonic nanohole array Detection  CFU in  µL Urine  min []
E. coli
Plasmonic nanohole array with
interferometry
Detection  CFU in  µL Diluted plasma  min []
E. coli
Dielectric BiMW Detection  CFU/mL B. cereus Buffer  min [, ]
 CFU/mL E. coli Ascetic fluid  min
Hydrogel D PhC Detection  CFU/mL E. coli Milk, orange juice, river water,
serum
–min []
Chirped long period fibre Detection  CFU/mL E. coli Buffer  min []
SPR Imaging  CFU Listeria Tryptic Soy Broth (TSB) < h []
Dielectric nanohole array metasurface Imaging  CFU E. coli Buffer < min []
aThe resolution is reported in CFU/mL when the aim is only to quantify bacterial concentration and in absolute number of bacteria when the
sensor localizes bacteria for imaging. bThe detection time reported is not intrinsic to the photonic techniques, but it is also affected the surface
functionalization protocol used to tether bacteria onto the sensors’ surface.
Table : State of the art of photonic nanotweezers for single bacterium trapping.
Configuration Power Trapping time Application Reference
V-groove plasmonic waveguide / / E. coli detection by
fluorescence signal
[]
Plasmonic nanoantenna 
μW/μm
> h Trapping and growth monitoring of multiple
individual E. coli
[]
Dielectric D PhC
(H, H, L cavities)
 µW > min Trapping of E. coli and
B. subtilis
[]
Dielectric D PhC
(nanobeam cavity)
∼ µW  min, > h, > h Single B. subtilis, E. coli,
S. epidermidis
[]
Dielectric D PhC
(side-coupled hollow cavity)
∼ µW Several minutes Differentiation between Gram-positive and
Gram-negative bacteria
[]
Lensed optical fibre  mW  min Dynamic observation of single E. coli []
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Table : Overview of photonic antimicrobial susceptibility tests in comparison with traditional microbiological and commercial solutions.
Class Methods Structure Detection principle Susceptibility
indicator(s)
Surface receptors/
labels
Drug
test
time*
Probed
bacteria
Sample nature
and volume
Reference
Traditional culture-based (macroscopic) Disk diffusion
(Kirby-Bauer)
Visual inspection Growth None – h Bulk
method
Isolates on MH
agar
[]
(Micro)broth
dilution
Colorimetric or OD
reading
Growth or metabolism None – h Bulk
method
Isolates in MH
broth ( μL/
well)
[]
Free-space optics
(microscopic
photonics)
Commercial
devices
VITEK
(BioMérieux)
OD and/or fluorescence
measurements
Growth, metabolism None – h Bulk
method
Isolates in saline
( mL)
[, ,
]
MicroScan
Walkway
OD and/or fluorescence
measurements
Growth Fluorophores – h Bulk
method
Isolates in saline
( mL)
[]
BD Phoenix OD and colorimetric
reading
Growth, metabolism Chromophores – h Bulk
method
Isolates in
Phoenix AST-S
broth (. mL)
[, ]
Forward laser light
scattering
BacterioScan® Small-angle scattered
light
Growth, morphology None – h > CFU/
mL
Isolate in saline/
urine ( mL/
well)
[,–
]
Flow cytometry Commercial flow
cytometers
Transmitted and/or scat-
tered light and/or
fluorescence
Cell count,
morphology, mem-
brane integrity
Fluorophores
(optional)
.– h  Isolates in MH
( mL)
Spiked blood
(. mL)
[, ]
Nanostructure-
enhanced
detection
Silicon
nanopillars
Optical interference Growth Wheat germ
agglutinin
(WGA)
– h > CFU/
mL
Isolate in PBS
( μL)
[]
D nanodisks
grating
Optical diffraction Growth, motility,
diffusivity
None – h >– Isolate in LB broth
( μL)
[]
Guided-wave optics
(nanoscopic
photonics)
Evanescent-wave
sensors
Gold thin film SPR SPR resonance angle Membrane integrity Poly-L-lysine .– h Not given Isolate in LB broth
(not given)
[]
Gold nanoholes Extraordinary optical
transmission
Growth Anti–E. coli
antibodies
 h > CFU/
mL
Isolate in PBS
( mL)
[]
Gold nano-
mushrooms
LSPR resonance
wavelength
Growth Conditioning layer  h Not
relevant
Isolate in LB broth
( μL)
[]
SiN D grating GMR resonance
wavelength
Growth None  h Not
relevant
Isolate in LB broth
( mL)
[]
Gold thin film SPR SPR imaging Nanomotion Anti–E. coli/APTES < h  Isolate in PBS
( μL)
[]
*The drug test time refers to the time needed to identify susceptibility in a pure bacterial colony, therefore does not include pre-culturing time for either sample isolation or enrichment (typically at
least overnight).
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3.3 Free-space photonic techniques
3.3.1 Elastic light scattering
Amore refined version of microdilution is the use of elastic
light scattering. While microdilution simply measures the
light absorbed by a growing bacterial culture, light-
scattering also analyses the angular intensity spectrum of
the light scattered by the bacterial sample, as schemati-
cally illustrated in Figure 5(d). The angular spectrum
carries two pieces of information: its intensity is propor-
tional to the number of scatterers, that is the bacterial
count, hence is a proxy for bacterial growth, whereas the
shape of the spectrumdepends on the size andmorphology
distribution and of the scatterers. These ideas were applied
to antibiotic testing as early as the 1970s, when Berkman
et al. [108] and Murray et al. [109] observed significant
differences in the light scattered by antibiotic-treated
versus untreated samples. The technology has been
improved since and has recently been commercialized as
the BacterioScan® instrument [26], which is especially
designed to analyse urine samples and related urinary tract
infections. The instrumentmeasures the forward laser light
scatter (FLLS), that is the laser intensity scattered by the
bacterial sample at small angles compared with the inci-
dent direction and can measure OD values 1 to 2 orders of
magnitude lower than traditional laser absorbance tech-
niques. Consequently, it can detect bacterial growth from a
much earlier stage, affording time to result of 2–6 h in urine
[110–112] and even in blood samples [113]. Notably, the
device can perform 16 tests simultaneously.
Even though FLLS affords parallel, multiplexed and
relatively fast measurements, it still struggles with con-
centrations lower than 104 CFU/mL (see Table 3). In
particular, BacterioScan is not suitable for single, or few,
bacteria measurements, such that the heterogeneity of
bacterial colonies is still disregarded. Another limitation is
that the optical probing volume is determined by an un-
focussed laser beam, hence macroscopic, and background
noise may interfere with the measurement.
3.3.2 Flow cytometry
A further application exploiting laser-light interaction with
bacteria is represented by flow cytometry, where the key
idea is to rapidly flow cells across a detection area illumi-
nated by a fixed light beam. Critically, the bacterial sus-
pension is hydrodynamically focussed through a nozzle, so
that individual cells pass through the laser beam, as illus-
trated in the schematic in Figure 5(e). Therefore, flow
cytometry restricts the interaction of light to individual cells
without the need for light structuring or confinement. Both
the transmitted/scattered light and possibly their fluores-
cence, if the cells are specifically tagged, are detected. The
scattered light enables counting cells and analysing their
size andmorphology,whilefluorescent labelling can inform
the presence of specific proteins or markers. By choosing
appropriate fluorophores, one can probe the mechanical
Figure 5: (a) Schematic illustration of the
Kirby-Bauer disk-diffusion antimicrobial
susceptibility test. Bacterial colonies are
spread uniformly onto an agar plate and
their susceptibility is determined by the
size of the inhibition zones surrounding the
antibiotic-impregnated disks. (b) Sche-
matic of a microdilution assay, where bac-
teria are exposed to serial dilution of
different drugs. Dark wells are indicative of
viable bacteria that have managed to
duplicate, whereas clear ones indicate that
bacteria did not grow. (c) Optical density
(OD) measurement scheme. A turbid solu-
tion contains higher concentrations of
bacteria, therefore absorb more light. (d)
Schematic of light scattering techniques,
whereby light transmitted and scattered by
the bacterial sample are bothmeasured. (e)
Flow cytometry working principle. Single
bacteria are flown across a laser beam to
detect both the transmitted light and
emitted fluorescence from single bacteria.
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integrity of the bacterial membrane and its functionality
(such as the membrane potential) as well as bacterial
viability. Thanks to this richness of information, flow
cytometryhas been successfullyused forAST,bothwith and
without fluorescent tagging, with time to result of 1.5–8 h
[114–116].
Themain advantages of flow cytometry are rapid assay
times and single-cell capability with high-throughput.
However, although tens of thousands of cells per second
can be flown through the laser beam and analysed, the
technique is rather demanding in terms of detection
equipment. Fast and sensitive detectors are required to
excite and reveal fluorescence at a frequency of up to
10 kHz. In addition, certain bacterial strains emit auto-
fluorescence, hence causing false positive/negative and
increasing noise [117].
3.3.3 Nanostructure-enhanced detection
The free-space photonic structures examined thus far do
not exploit any nanostructure to shape or interact with
light.Wenowconsider approaches that use nanostructures
to generate interferometric or diffractive effects and
examine whether advantages can be gained from these
structures for the assessment of bacteria. Importantly, field
enhancement does not play a role in the particular struc-
tures examined in this section as they do not confine light.
Instead, nanostructuring is used to generate interference
and diffraction which increase sensitivity to bacterial
growth so that rapid ASTs can be performed.
For example, Volbers et al. [118] exploited the diffraction
generated by a gratingmade of a 2D array of gold nanodisks.
The intensity of the first-order diffraction mode is recorded
by a CMOS camera placed at an appropriate angle, as seen in
Figure 6(a). Bacteria growing onto or above the grating sur-
face (see the Scanning Electron Microscope (SEM) picture in
the inset of Figure 6(a)), disturb the diffraction because they
act as additional scattering centres. As a result, the decrease
and fluctuations of intensity in the diffracted mode are
monitored and linked to the number of bacteria and their
motility, respectively. Figure 6(b) shows how the decrease of
diffraction intensity depends to the number of bacteria.
Notably, the system is sufficiently sensitive to pick up the
presence of a few (1–5) bacteria within the observed grating
area of (120 × 120) μm2.
The system was then used to determine the MIC of
several bacterial strains exposed to three different antibi-
otics and susceptibility was demonstrated within 2–3 h.
Figure 6(c) shows the case of ampicillin by plotting the
change in diffracted mode intensity over time and for
different concentrations of the drug. The constant intensity
over time observed for concentrations of ampicillin higher
than 2mg/mL is indicative of no growth, and therefore drug
efficacy. Interestingly, the fluctuations in intensity are
shown to be an even earlier predictor of susceptibility than
intensity alone, pointing to motility as an early indicator of
susceptibility. For example, the action of ampicillin was
detected in 20–30 min as a significant decrease of the
normalized standard deviation of the intensity traces, as
illustrated in Figure 6(d) for a susceptible E. coli strain, as
opposed to the 1.5–2 h required for distinguishing the in-
tensity curves in Figure 6(c). Conversely, the signal
collected from resistant bacteria shows continuously
increasing fluctuations due to the increasing number of
bacteria contributing to the signal (see Figure 6(e)).
This observation is in agreement with the study of
fluctuations conducted on other platforms, such as hy-
drodynamic trapping of individual bacteria or the electrical
fluctuations induced by a few tens of bacteria in a micro-
fluidic channel [25, 119]. Similarly, monitoring the nano-
motion of bacteria tethered to AFM cantilevers produced
compatible results in terms of detection time [24, 120].
Overall, these findings suggest that measuring bacterial
fluctuations, which are proportional to bacterialmotility, is
a more powerful and earlier indicator of viability than
growth, so is worth exploring further as a reporter of sus-
ceptibility to antibiotics. A further advantage of the nano-
disk configuration is that no surface receptors are required
because the bacteria do not need to be in direct contact
with the surface to disturb the diffraction.
We note that other macroscopic and free-space tech-
niques are not able to record the motility of a few bacteria
either because they average over a much larger number of
bacteria or they only obtain temporary information (such
as flow cytometry). Conversely, the nanodisk are much
more sensitive, such that they can record as few as 1–5
bacteria (see Figure 6(b)), therefore allowing for both
bacterial division and fluctuations to bemonitored from an
early stage.
Another example that utilizes nanostructures to create
Fabry-Pérot resonances was proposed by Leonard et al.
[121]. Their sensor is based on a silicon micropillar array
with a functionalized surface to bind bacteria, as shown in
the SEM picture in Figure 6(f). The micropillar array gen-
erates Fabry-Pérot fringes in the vertical direction, with
interference happening between the portion of the beam
reflected off the top of pillars and the one reflected off the
bottom. The presence of bacteria modifies the refractive
index between the pillars and, consequently, the optical
phase, resulting in a shift of the fringes (see Figure 6(g)).
Bacteria were grown on the array and the shift of the
fringes was monitored over time as a proxy of bacterial
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growth. As Figure 6(h) shows, the signal behaves differently
when the antibiotic ceftriaxone is added to the bacterial
culture compared with a control experiment without anti-
biotic. Specifically, no increase in signal is observed when
bacterial growth is inhibited (red curve), as opposed to the
no-drug case,where growth occurs instead (blue curve). The
different growth conditions were verified with fluorescent
imagesas shown in the top rowofFigure6(h). The technique
Figure 6: (a) Schematic of the measurement setup used by Volbers et al. [118]. The inset shows a false-colour Scanning Electron Microscope
(SEM) image of the nanodisk array and a single Escherichia coli. Scale bar: 2 μm. (b) Mean decrease in diffraction intensity as a function of the
number of bacteria above the grating. (c) Change of diffraction intensity in the presence of different concentrations of ampicillin. (d–e)
Normalized change of standard deviation of the intensity fluctuations for susceptible and resistant E. coli in the presence of 8 mg/mL of
ampicillin. (f) False-colour SEMpicture of E. coli situated between the siliconmicropillars fabricated by Leonard et al. [121]. Scale bar: 1 μm. (g)
Interference fringes measured on illumination of the micropillar array. (h) Fluorescent images and percentage change of optical path
difference as a functionof time for E. coligrowingover themicropillar in clear growingmediumand ceftriaxone. Scale bar: 10μm. (i) Percentage
change of optical path difference over time for different concentrations of ceftriaxone.
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was also able to measure MIC values. For example,
Figure 6(i) shows that for concentrations of ceftriaxone
greater than 0.01 μg/mL, no change in phase is observed
over time. Conversely, for lower concentrations of antibi-
otics, a significant increase is observed, hence allowing an
MIC value to be determined within 2–3 h of monitoring.
In this case, the enhanced light-bacteria interaction
offered by the Fabry-Pérot resonance affords higher
sensitivity compared with traditional free-space interac-
tion or OD measurement. Even though bacterial growth is
still being used as a signature, here the bacterial optical
mass is being picked up interferometrically, which in
general affords higher sensitivity. Although the principle of
phase-based detection has beenwidely used in biosensing,
it has not been asmuch exploited for bacterial drug testing,
therefore representing an interesting opportunity for future
developments. In fact, exploiting optical interference
enabled a reduction of detection time from 2–16 h, typical
for free-spacemethods, to 2–3 h, as summarized in Table 3.
3.4 Evanescent wave-based ASTs
In contrast to the free-space techniquesdescribedpreviously,
evanescent-wave sensors are based on guided modes and
resonances and they interact with the analyte via their
evanescent tail. The confinement of the evanescent tail to
within a few hundreds of nanometres from the interface clas-
sifiesthesedevicesassurfacesensorsandimpliesthatonlythe
cell wall of the first layer of bacteria is probed, as described in
the introduction and underpinned by equation (1). We there-
fore classify these techniques as nanoscopic, as indicated in
Table 3, in contrast to microscopic techniques that instead
probe the entire cell. Interestingly, someof the techniques are
only nanoscopic in one dimension, that is they probe the
bacteriumwithinafewhundrednanometresof thesurfacebut
average over an illuminated area of 100s of μm or evenmilli-
metres, whereas others aremuchmore localized and are able
to probe individual bacteria. SPRi or hyperspectral imaging
with GMRs [20, 49, 79], fall into the latter category.
Regarding sensors that probe a larger area, one of the
first examples was reported by Chiang et al. [23], who used
an SPR sensor functionalized with poly-L-lysine to
encourage bacterial adhesion and made two important ob-
servations. First, bacteria susceptible to ampicillin showeda
reduction of refractive index compared with resistant bac-
teria on exposure to ampicillin. This indicates attack of the
cellmembrane and is consistentwith the fact that ampicillin
inhibits bacterial cell wall synthesis (see the light-grey curve
in Figure 7(a)). Second, the sensor can discriminate between
the actions of different drugs. Tetracycline, for example,
binds to the bacterial ribosomes and inhibits protein syn-
thesis, but does not affect the cell wall. Correspondingly,
very little reduction in refractive index was observed after
the administration of the antibiotic. Instead, the inhibition
of protein synthesis causes delayed and irregular fluctua-
tions in the SPR angle as a distinct signature (see the dark-
grey curve in Figure 7(a)).
Importantly, these changes are measured on a short
timescale because of the surface sensitivity; the evanescent
tail of the mode is able to directly interact with the bacterial
membrane and to monitor any changes instantaneously.
Therefore, theprocess is limited by thebiological timescale of
the drug’s action and not by the sensitivity of the
measurement.
Similarly, the high surface sensitivity of the confined
optical mode can also be used to monitor bacterial growth
directly and on a much shorter timescale than traditional
growth assays. This effect was exploited by Kee et al. [122]
who functionalized the surface of a gold nanohole array
with antibodies to monitor the growth of tethered E. coli.
Figure 7(b) displays a sketch of the structure and an SEM
image of a fabricated array, whereas Figure 7(c) shows the
wavelength shift induced by bacteria growing on the sen-
sor’s surface. Because the bacteria were resistant to
ampicillin but susceptible to tetracycline, a different
behaviour was observed on exposure to the two drugs. In
the presence of ampicillin, bacteria kept attaching and
growing, hence increasing surface coverage over time and
resulting in a continuous increase of the wavelength shift
(blue curve). Conversely, tetracycline inhibited bacterial
growth, which is evidenced by the immediate flattening of
the curve after the addition of antibiotics (red curve).
As another example, the strong light confinement
offered by localized surface plasmon resonances (LSPRs)
on nanoparticles has been applied to speed up suscepti-
bility testing of bacterial biofilms compared with tradi-
tional techniques. LSPRs are collective oscillations of free
electrons induced by light in subwavelength metallic
nanoparticles. On resonance, the electric field at the sur-
face of the nanoparticle is strongly enhanced and decays
with a short distance (tens of nanometre), thereby enabling
evanescent-wave optical sensing [123, 124]. Funari et al.
[125] fabricated gold nanoparticles supported by silica
pillars, as shown in the sketch in Figure 7(d) and imaged in
Figure 7(e). These structures, dubbed gold nanomush-
rooms, support a broad (Q ≲ 10) LSPR mode which was
used to monitor an E. coli biofilm forming over the surface
in the presence of different antibiotics.
By measuring the wavelength shift of the LSPR mode,
the authors showed that biofilm formation is only party
hindered by drugs that target the bacterial adhesion
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ability, in particular rifapentine [126]. Figure 7(f) plots the
wavelength shift as a function of antibiotic, whereby a
negative shift indicates sustained growth while a positive
or zero shift indicates that biofilm is not fully forming. The
partial efficacy of rifapentine is suggested by the negative
shift in resonance wavelength of similar magnitude to that
of an untreated sample (grey and red bars in Figure 7(f)).
Biofilm formation is then inhibited more effectively by
pairing rifapentine with a bactericidal drug, such as
ampicillin or kanamycin, as evidenced by the black bar in
Figure 7(f), which shows the smallest wavelength shift,
indicative of no biofilm growth. Notably, the authors were
Figure 7: (a) Shift of surface plasmon resonance (SPR) angle induced by exposing susceptible Escherichia coli tethered on the SPR sensor to
ampicillin and tetracycline [26]. (b) Sketch of the gold nanoholes used by Kee et al. and Scanning Electron Microscope (SEM) image of a
fabricated array [122]. Scale bar: 200 nm. (c) Resonance wavelength shift for ampicillin resistant and tetracycline susceptible in the presence
of ampicillin (blue curve) and tetracycline (red curve). (d) Gold nanomushroom array proposed by Funari et al. [125], (e) SEM image of the
nanomushroom sensor’s surface. (f) Wavelength shift for growing biofilm in presence of different antibiotics. (g) SEM image of a Si3N4 grating
supporting aGMRmode. (h) Resonancewavelength shift for an E. coli biofilm growing over the grating and later exposed to ciprofloxacin [128].
(i) Confocal microscopy showing an established biofilm (top panel) and confirming the disruption of the biofilm (bottom panel). Scale
bar = 10 μm.
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able to reach this conclusion in 2–3 h and with a relatively
simple measurement configuration. This was enabled by
the light confinement at the surface making the sensor
sensitive only to the cell membrane of the first layer of
bacteria, similar to other evanescent-wave sensors dis-
cussed in this section.
As an alternative to plasmonic resonances, we recently
presented related work using GMRs excited in Si3N4 grat-
ings (see Figure 7(g)). GMRs are quasi-guided modes
excited in the near-wavelength regime of a grating [127].
Electromagnetic energy is confined in the slab, therefore
resulting in the generation of an evanescent wave at the
surface. The mode, however, can be readily coupled out to
external radiation because of its leaky nature,whichmakes
GMRs attractive because of the ease of measurement [20].
We exploited both the surface sensitivity and the spatial
localization offered by the GMR mode to monitor the bot-
tom layer of the biofilm as well as image the biofilm
morphology and spatial distribution through hyper-
spectral imaging [128].
Similar to the plasmonic methods, the biofilm devel-
opment and response to antibiotics was monitored at
different time points, especially at the early stages of biofilm
establishment.We showed thatwhile somedrugsmay affect
the top surface of the biofilm, they do not eradicate it.
Conversely, antibiotics effective at destroying the biofilm,
such as ciprofloxacin, caused a decrease of the resonance
wavelength (see Figure 7(h)), thereby indicating that the
bottom layerwasbeingaffected to theextent that itdetached
from the surface. The result was verified by confocal mi-
croscopy with live/dead staining, as shown in Figure 7(i),
wherealivebacteriaappeargreenanddeadonesappear red.
Notably, the grating surfacewas not functionalizedwith any
capture molecules and did not require any fluorescent
labelling. These aspects are particularly important for real
applications where the species of the biofilm-forming bac-
teria may not be known. In that case, functionalizing the
surface with antibodies that target specific bacterial mem-
brane proteins may miss the bacteria of interest. As a
downside, the lack of functionalization delayed the attach-
ment of the bacteria and their colonization of the surface.
These examples show that monitoring the first and
arguably most important layer of the biofilm leads to the
early detection of its formation. Furthermore, it allows
monitoring very clearly the attack by some antimicrobials
compared with traditional techniques that are destructive
and require either lengthy and resource-consuming stain-
ing procedures or a confocal microscope to observe the
bottom layer [129].
Overall, these techniques offer several interesting in-
sights. First, physical changes induced by antibiotics to the
bacterial membrane can be detected on a timescale shorter
or comparable with that of growth by cell division, with the
surface sensitivity being a particular asset. Second, sensing
Figure 8: (a) Diagram of the SPR sensor
demonstrate by Syal et al. [51]. (b) SPR
contrast images of a single Escherichia coli
tethered on the gold surface at different
time points. Scale bars: 2 μm (c)
z-movement of a single bacterium over
time, before and after the addition of
0.5 mg/mL of polymyxin B. (d) Distribution
of nanomotion amplitudes of different
individual bacteria before (blue bars) and
after (red bard) exposure to the antibiotic.
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with a guided mode reduces time even for a growth assay
because the guided mode is sensitive to a single layer of
bacteria, therefore enabling the detection of bacterial di-
vision at a much lower bacterial concentration. Notably,
none of the traditional microbiological techniques enables
such an insightful observation and reduction in time.
Because of the increased sensitivity and reduction of
detection time offered by sensing fewer bacteria with an
evanescent tail, one would expect that pushing light-matter
interaction to the level of individual bacteria would further
reduce detection time. In fact, this reduction has been
demonstrated by using SPRi [51]. As introduced in Section
2.1.4. The SPRi configuration, sketched in Figure 8(a), was
used to monitor a single bacterium tethered to the surface
via antibody binding. The contrast of the image fluctuates
over time because of themotion of the boundbacteria as the
bacterium moves within the evanescent tail of the resonant
mode, as shown in Figure 8(b). The fluctuations in intensity
can be converted into a z-movement of the bacterium
because the exponential decay is well known (equation 1)
and can be used to quantify the bacterial motion perpen-
dicular to the surface.
After the exposure of tethered bacteria to 0.5mg/mL of
the antibiotic polymyxin B, the bacterial motion is almost
immediately reduced to levels comparable with the fluc-
tuations of dead bacteria, as illustrated in Figure 8(c).
Although the authors ascribe the sudden decrease to the
loss of viability and halting of the bacterial metabolism, it
is important to note that the impressively rapid response is
due to the very high concentration of antibiotic used,
which corresponds to 25 times the MIC for polymyxin B.
Nevertheless, when the bacteria are exposed to a near-MIC
concentration, a similar response occurs within 1 h, which
is still much faster than conventional tests. Moreover, the
single-cell capability afforded by the SPRi method allows
probing bacterial heterogeneity by studying the distribu-
tion of nanomotion amplitudes of tens of individual bac-
teria as shown in Figure 8(d).
The response time was also confirmed in later work
from the same group, where the nanomotion was measured
with a simple brightfield microscope. It was observed that a
near-MICof the same antibiotic, the decrease innanomotion
happened over 1–1.5 h [130]. Although this second config-
uration is inherently easier to operate, it can only detect 2D
nanomotion across the plane where bacteria attach.
Nevertheless, in this second work, the single-cell capability
allowed the authors to distinguish subpopulations showing
different sensitivities to the antibiotic administration. This is
a clear example of heteroresistance, a phenomenon that,
despite being crucial to characterizing the response of a
bacterial population to an antibiotic treatment [11, 12, 131], is
commonly neglected in traditional bulk experiments.
4 Conclusions
Wehave reviewed and critically assessed progress in the use
of photonic and nanophotonic techniques for the detection
and monitoring of bacteria. By comparing the more
advanced sensing and imaging techniques against con-
ventional methods, we have attempted to answer the
question of what added value nanophotonics can bring to
the detection of bacteria and,more specifically, to the global
problem of antimicrobial resistance. How do nanophotonic
techniques allow us to better assess the response of bacteria
to antibiotic challenge, that is to assess their susceptibility?
Conventional techniques, such as the Kirby-Bauer test,
used in every hospital laboratory are based on measuring
the growth of entire bacterial colonies. Naturally, it takes at
least an overnight incubation for bacteria to grow to a con-
centration that is detectable by visual inspection or quanti-
fiable by a traditional ODmeasurement (OD600) [96, 97, 132].
We refer to this is a “macroscopic” test. By observing the
growthof fewerbacteria,weenter the “microscopic” regime,
whereby changes in individual bacteria can be detected. A
number of techniques, such as flow cytometry [114, 116],
forward laser light scattering [26, 109] and nanostructure-
enhanced methods [118, 121] can provide such microscopic
information and allow us to reduce the assessment of sus-
ceptibility from 24–48 h down to 2–6 h (see Table 3), simply
because they are able to observe a small number of bacteria
rather than large colonies.
Reducing the spatial dimension further, we enter the
“nanoscopic” domain, where only a part of the bacterium
is interrogated, most notably the cell wall. Guided mode
and resonant techniques such as those based on surface
plasmons or dielectric resonances allow us to enter this
regime because they are all based on the interaction be-
tween the evanescent tail of a confined mode and the
outside of the bacterium. This reduction in scale gives a
further reduction in assessment time, down to 0.5–2 h, as
highlighted in Table 3. This further decrease is enabled by
increasing the sensitivity to bacterial growth because only
the first layer of adherent bacteria is probed by the
evanescent tail [23, 122], therefore affording to probe
growth from amuch earlier stage. Such configuration lends
itself to the study of real-time biofilm growth [125, 128],
where the bottom layer is crucial, and represents an
attractive alternative to traditional cumbersome micro-
scopy or staining protocols [129].
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In terms of sensitivity, we have also highlighted a
number of techniques that successfully use interferometry
to amplify the observation of bacterial presence. As is well
known, phase-based measurements are among the most
sensitive in photonics, so it is no surprise that this strategy
is also successful in the detection andmonitoring of a small
number of bacteria, both formeasuring low concentrations
[68–70] and for assessing bacterial susceptibility to anti-
biotics [121].
Another parameter that is not picked up by
culturing methods is the heterogeneity of the bacterial
response. Bacteria, like any other living organism,
exhibit heterogeneity, so it is an oversimplification to
assume that they all respond in the same way. Ignoring
heterogeneity is a mistake made by every averaging
method such as culturing. In particular, it ignores the
issue of heteroresistance and the presence of persister
cells [10, 12]. Flow cytometry [114, 116] and droplet
microfluidics [131] are already able to pick up hetero-
geneity, but only at the microscopic scale. We therefore
see exciting opportunities for techniques such as SPRi
[51] or GMR imaging [32, 79] to add their nanoscale
sensing ability to this problem.
In addition, the strong light-bacterium interaction
provided by nanoscopic techniques allows probing bacte-
rial properties alternative to growth, with extreme sensi-
tivity, that escape the traditional Kirby-Bauer test. A first
example is the OD of the bacterial cell wall [22, 23], which
was shown to be affected by antibiotics on a timescale
comparable to or shorter than the bacterial division time.
This suggests that changes to the cell wall become evident
before the bacterium exhibits changes on a microscopic
scale and represent a further avenue worth exploring for
future ASTs. The OD of the cell wall was also exploited to
identify different bacteria and classify Gram-positive and
Gram-negative strains [21, 22].
Similar to the cell wall, the ability of bacteria to swim
and colonize surfaces has been used as a signature of their
viability,whereby a significant reduction inphysicalmotion
can be interpreted as an indicator of a successful antibiotic
challenge. A number of articles we highlight [51, 118, 130]
have demonstrated this phenomenon by using nano-
photonic techniques and have also verified it against con-
ventional susceptibility tests that nanomotion and motility
are relatively fast (∼1 h) indicators of susceptibility.
Altogether, these findings indicate that the ability to
optically assess bacteria on a nanoscopic length scale al-
lows us to observe antibiotic susceptibility on a biological
timescale rather than on a timescale dictated by physical
observation. This marks a profound change and improve-
ment on the Kirby-Bauer test.
Importantly, we note that the advantage of using some
of these indicators alternative to growth is also supported by
other findings which do not necessarily use photonics, such
asmicrofluidic techniques [25, 119, 133, 134], AFM cantilever
deflection [24, 120, 135] or electrochemical platforms [136–
138]. For example, bacterial metabolism drives ion-
exchange across the membrane, so we see the measure-
ment of electrical impedance at the single-cell level as a very
promising method that could be added to the toolkit [90,
136]. These observations suggest that a synergistic approach
betweendifferent domains is desirable, as itmight be able to
provide even greater insight and meet important needs that
still pose challenges. For instance, microfluidics is crucial
for tasks such as sample handling, filtration, delivery and
enrichment while requiring low volumes of solutions [15,
28]. Therefore, further developments in microfluidics are
expected to bring significant benefit to photonic biosensors.
Bacterial identification is also challenging and currently
requires lengthy cultivation and specialized personnel. In
this respect, Raman [139–142] and IR spectroscopy [143, 144]
represent promising alternative candidates to address the
issue, while also being able to carry out susceptibility tests.
For these reasons, overall, we believe that the ideal
bacterial detection and testing device will likely be multi-
parametric, thereby making it able to measure several pa-
rameters at the same time. In fact, it seems naive to assume
that the diversity of the bacterial world can be captured by
measuring a single parameter; similarly, antibiotics have
many different modes of action. Antibiotic susceptibility is
a multidimensional problem that can only be solved with a
multiparameter approach. Several techniques have
already recognized this need by measuring multiple re-
sponses in parallel, for example, morphology in conjunc-
tion with motility [25] or single-cell division [132, 133],
electrical impedancewithmotility [90] or bacterial division
[138], as well as growth and motility [118].
Photonics can play a significant role in this develop-
ment roadmap, thanks to the desirable features we high-
lighted in this article. However, despite some of the
conceptual leaps described here, no real major techno-
logical breakthrough has happened at the clinical level
since Kirby and Bauer developed their disk diffusion test.
This is due to some major hurdles that still need to be
overcome to make these platforms suitable for translation
into the clinic.
First, it is important to note that most of the photonic
techniques discussed here only address part of the issues of
current ASTs in terms of total assay time. In fact, an
important bottleneck of currentASTs is the timeneeded for a
clinical sample to be precultured to isolate a pure bacterial
colony. All the photonic techniques presented here were
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tested directly with a pure colony or a standardizes inoc-
ulum, namely a known bacterial strain which was cultured
overnight and then suspended in a known medium [4, 5].
This implies that the reduction in assay time discussed
throughout this review only concerns the time needed for
the actual detection of susceptibility (termed drug test time
in Table 3), not for the entire AST process. To reduce the
entire assay time, a synergistic approach with microfluidics
and other photonics identification techniques is expected to
bring significant advantages, as discussed previously.
Second, such emerging devices ought to be made
scalable and cost-effective. Reducing the optical probed
volume often comeswith the need of using nanostructures,
whose fabrication requires electron beam lithography and
cleanroom procedures, which are neither easy nor cost-
effective to scale. Although significant progress has been
made in this direction and many point of care detection
platforms have been demonstrated [65, 145, 146], these
devices still need to be validated for reproducible and ac-
curate on-field operation. In addition, many portable
technologies still suffer from insufficient sensitivity to be
able to perform early diagnosis [147]. To this purpose, we
expect technologies such as nanoimprint lithography,
3D printing and paper microfluidics to play important roles
in nanostructures fabrication, sensor assembly and
microfluidic circuitry realization, respectively. This will
contribute to decreasing cost and making nanophotonic
technologies easier to translate [148].
Finally, becausemany of these novel techniques are still
emerging, they need to be extensively tested, both at the
research level and in the clinic to meet the stringent re-
quirements of regulatory bodies. These regulations entail
lengthy and costly validations, which are however necessary
to ensure safety, performance and low rates of errors.
Broader targets of this testing include reproducibility, fidelity
and applicability to the largest possible number of bacteria-
drug combinations. In this context, closer collaborations
with clinicians, microbiologists and health economists is of
paramount importance to assess the viability of developed
platforms and their impact on the health care system.
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Houdré, “Observation of backaction and self-induced trapping
in a planar hollow photonic crystal cavity,” Phys. Rev. Lett., vol.
110, p. 123601, 2013.
[87] T. Van Leest and J. Caro, “Cavity-enhanced optical trapping of
bacteria using a silicon photonic crystal,” Lab Chip, vol. 13,
pp. 4358–4365, 2013.
[88] J. Juan-Colás, A. Parkin, K. E. Dunn, M. G. Scullion, T. F. Krauss,
and S. D. Johnson, “The electrophotonic silicon biosensor,”
Nat. Commun., vol. 7, pp. 1–7, 2016.
[89] J. Juan-Colás, T. F. Krauss, and S. D. Johnson, “Real-time
analysis of molecular conformation using silicon
electrophotonic biosensors,” ACS Photonics, vol. 4,
pp. 2320–2326, 2017.
[90] D. Conteduca, G. Brunetti, F. Dell’Olio, M. N. Armenise, T. F.
Krauss, and C. Ciminelli, “Monitoring of individual bacteria
using electro-photonic traps,” Biomed. Opt. Express, vol. 10,
p. 3463, 2019.
[91] H. Xin, Q. Liu, and B. Li, “Non-contact fiber-optical trapping of
motile bacteria: dynamics observation and energy estimation,”
Sci. Rep., vol. 3, pp. 1–8, 2014.
[92] M. Tardif, J. B. Jager, P. R.Marcoux, et al., “Single-cell bacterium
identification with a SOI optical microcavity,” Appl. Phys. Lett.,
vol. 109, 2016.
[93] J. C. Lagier, S. Edouard, I. Pagnier, O. Mediannikov, M.
Drancourt, and D. Raoult, “Current and past strategies for
bacterial culture in clinical microbiology,” Clin. Microbiol. Rev.,
vol. 28, pp. 208–236, 2015.
[94] J. H. Jorgensen and M. J. Ferraro, “Antimicrobial susceptibility
testing: a review of general principles and contemporary
practices,” Clin. Infect. Dis., vol. 49, pp. 1749–1755, 2009.
[95] B. Behera, G. K. Anil Vishnu, S. Chatterjee, et al., “Emerging
technologies for antibiotic susceptibility testing,” Biosens.
Bioelectron., vol. 142, 2019.
[96] A. W. Bauer, “Single-disk antibiotic-sensitivity testing of
staphylococci,” AMA Arch. Intern. Med., vol. 104, p. 208, 1959.
[97] C. A. Rotilie, R. J. Fass, R. B. Prior, and R. L. Perkins,
“Microdilution technique for antimicrobial susceptibility
testing of anaerobic bacteria,” Antimicrob. Agents Chemother.,
vol. 7, pp. 311–315, 2012.
[98] D. H. Pincus, “Microbial identification using the bioMérieux
VITEK® 2 system,” Encycl. Rapid Microbiol. Methods, pp. 1–32,
2010.
[99] A. McGregor, F. Schio, S. Beaton, V. Boulton, M. Perman, and G.
Gilbert, “The microscan walkaway diagnostic microbiology
system—An evaluation,”Pathology, vol. 27, pp. 172–176, 1995.
[100] K. C. Carroll, B. D. Glanz, A. P. Borek, et al., “Evaluationof the BD
Phoenix automated microbiology system for identification and
antimicrobial susceptibility testing of Enterobacteriaceae,”
J. Clin. Microbiol., vol. 44, pp. 3506–3509, 2006.
[101] A. Lupetti, S. Barnini, B. Castagna, P. H. Nibbering, and M.
Campa, “Rapid identification and antimicrobial susceptibility
testing of Gram-positive cocci in blood cultures by direct
inoculation into the BD phoenix system,” Clin. Microbiol.
Infect., vol. 16, pp. 986–991, 2010.
[102] M. Ligozzi, S. Barnini, B. Castagna, A. L. Capria, and P. H.
Nibbering, “Rapid identification and antimicrobial
susceptibility profiling of Gram-positive cocci in blood cultures
with the Vitek 2 system,” Eur. J. Clin. Microbiol. Infect. Dis., vol.
40, pp. 89–95, 2002.
[103] F. Garcia-Garrote, E. Cercenado, and E. Bouza, “Evaluation of a
new system, VITEK 2, for identification and antimicrobial
susceptibility testing of enterococci,” J. Clin. Microbiol., vol. 38,
pp. 2108–2111, 2000.
[104] J. L. Burns, L. Saiman, S. Whittier, et al., “Comparison of two
commercial systems (Vitek and MicroScan-WalkAway) for
antimicrobial susceptibility testing of Pseudomonas
aeruginosa isolates from cystic fibrosis patients,” Diagn.
Microbiol. Infect. Dis., vol. 39, pp. 257–260, 2001.
[105] H. S. Sader, T. R. Fritsche, and R. N. Jones, “Accuracy of three
automated systems (MicroScan WalkAway, VITEK, and VITEK 2)
for susceptibility testing of,” Society, vol. 44, pp. 1101–1104,
2006.
[106] C. Kulah, E. Aktas, F. Comert, N. Ozlu, I. Akyar, and H. Ankarali,
“Detecting imipenem resistance in Acinetobacter baumannii by
automated systems (BD Phoenix, Microscan WalkAway, Vitek
2); high error rateswithMicroscanWalkAway,” BMC Infect. Dis.,
vol. 9, pp. 1–7, 2009.
[107] E. A. Idelevich, D. A. Freeborn, H. Seifert, and K. Becker,
“Comparison of tigecycline susceptibility testing methods for
multidrug-resistant Acinetobacter baumannii,” Diagn.
Microbiol. Infect. Dis., vol. 91, pp. 360–362, 2018.
[108] R.M. Berkman, P. J.Wyatt, andD. T. Phillips, “Rapiddetection of
penicillin sensitivity in Staphylococcus aureus,” Nature, vol.
228, pp. 458–460, 1970.
[109] J. Murray, P. Evans, and D. W. L. Hukins, “Light-scattering
methods for antibiotic sensitivity tests,” J. Clin. Pathol., vol. 33,
pp. 995–1001, 1980.
[110] A. L. Roberts, U. Joneja, T. Villatoro, E. Andris, J. A. Boyle, and J.
Bondi, “Evaluation of the BacterioScan 216Dx for standalone
preculture screen of preserved urine specimens in a clinical
setting,” Lab. Med., vol. 49, pp. 35–40, 2018.
[111] F. Hassan, H. Bushnell, C. Taggart, et al., “Evaluation of
BacterioScan 216Dx in comparison to urinalysis as a screening
tool for diagnosis of urinary tract infections in children,” J. Clin.
Microbiol., vol. 57, pp. 1–7, 2019.
[112] J. V. Bugrysheva, C. Lascols, D. Sue, and L. M. Weigel, “Rapid
antimicrobial susceptibility testing of Bacillus anthracis,
Yersinia pestis, and Burkholderia pseudomallei by use of laser
light scattering technology,” J. Clin. Microbiol., vol. 54,
pp. 1462–1471, 2016.
[113] E. A. Idelevich, M. Hoy, D. Knaack, et al., “Direct determination
of carbapenem-resistant Enterobacteriaceae and
Pseudomonas aeruginosa from positive blood cultures using
laser scattering technology,” Int. J. Antimicrob. Agents, vol. 51,
pp. 221–226, 2018.
[114] M. A. C. Broeren, Y. Maas, E. Retera, and N. L. A. Arents,
“Antimicrobial susceptibility testing in 90 min by bacterial cell
countmonitoring,” Clin.Microbiol. Infect., vol. 19, pp. 286–291,
2013.
[115] T. H. Huang, Y. L. Tzeng, and R. M. Dickson, “FAST: rapid
determinations of antibiotic susceptibility phenotypes using
label-free cytometry,” Cytometry A, vol. 93, pp. 639–648, 2018.
4470 G. Pitruzzello et al.: Nanophotonics for bacteria
[116] D. Fonseca e Silva, A. Silva-Dias, R. Gomes, et al., “Evaluation of
rapid colistin susceptibility directly from positive blood
cultures using a flow cytometry assay,” Int. J. Antimicrob.
Agents, vol. 54, pp. 820–823, 2019.
[117] L. Yang, Y. Zhou, S. Zhu, T. Huang, L. Wu, and X. Yan, “Detection
and quantification of bacterial autofluorescence at the single-
cell level by a laboratory-built high-sensitivity flow cytometer,”
Anal. Chem., vol. 84, pp. 1526–1532, 2012.
[118] D. Volbers, V. K. Stierle, K. J. Ditzel, et al., “Interference
disturbance analysis enables single-cell level growth and
mobility characterization for rapid antimicrobial susceptibility
testing,” Nano Lett, vol. 9, no. 2, pp. 643–651, 2019.
[119] V. Kara, C. Duan, K.Gupta, S. Kurosawa, D. J. Stearns-Kurosawa,
and K. L. Ekinci, “Microfluidic detection of movements of
Escherichia coli for rapid antibiotic susceptibility testing,” Lab
Chip, vol. 18, pp. 743–753, 2018.
[120] H. Etayash, M. F. Khan, K. Kaur, and T. Thundat, “Microfluidic
cantilever detects bacteria and measures their susceptibility to
antibiotics in small confined volumes,” Nat. Commun., vol. 7,
p. 12947, 2016.
[121] H. Leonard, S. Halachmi, N. Ben-Dov, O. Nativ, and E. Segal,
“Unraveling antimicrobial susceptibility of bacterial
networks on micropillar architectures using intrinsic phase-
shift spectroscopy,” ACS Nano, vol. 11, pp. 6167–6177,
2017.
[122] J. S. Kee, S. Y. Lim, A. P. Perera, Y. Zhang, and M. K. Park,
“Plasmonic nanohole arrays for monitoring growth of bacteria
and antibiotic susceptibility test,” Sensors Actuators B Chem.,
vol. 182, pp. 576–583, 2013.
[123] S. Szunerits and R. Boukherroub, “Sensing using localised
surface plasmon resonance sensors,” Chem. Commun., vol. 48,
pp. 8999–9010, 2012.
[124] E. Petryayeva and U. J. Krull, “Localized surface plasmon
resonance: nanostructures, bioassays and biosensing – A
review,” Anal. Chim. Acta, vol. 706, pp. 8–24, 2011.
[125] R. Funari, N. Bhalla, K. Y. Chu, B. Söderström, and A. Q. Shen,
“Nanoplasmonics for real-time and label-free monitoring of
microbial biofilm formation,” ACS Sensors, vol. 3,
pp. 1499–1509, 2018.
[126] M. C. Maher, J. Y. Lim, C. Gunawan, and L. Cegelski, “Cell-based
high-throughput screening identifies rifapentine as an inhibitor
of amyloid and biofilm formation in Escherichia coli,” ACS
Infect. Dis., vol. 1, pp. 460–468, 2016.
[127] S. S. Wang and R. Magnusson, “Theory and applications of
guided-mode resonancefilters,”Appl.Opt., vol. 32, p. 2606, 1993.
[128] Y. Wang, C. P. Reardon, N. Read, et al. “Attachment and
antibiotic response of early-stage biofilms studied using
resonant hyperspectral imaging,” Under Review, https://arxiv.
org/abs/2009.03451.
[129] F. Pantanella, P. Valenti, T. Natalizi, D. Passeri, and F. Berlutti,
“Analytical techniques to study microbial biofilm on abiotic
surfaces: Pros and cons of the main techniques currently in
use,” Ann. Ig., vol. 25, pp. 31–42, 2013.
[130] K. Syal, S. Shen, Y. Yang, S. Wang, S. E. Haydel, and N. Tao,
“Rapid antibiotic susceptibility testing of uropathogenic E. coli
by tracking submicron scale motion of single bacterial cells,”
ACS Sensors, vol. 2, pp. 1231–1239, 2017.
[131] O. Scheler, K. Makuch, P. R. Debski, et al., “Droplet-based
digital antibiotic susceptibility screen reveals single-cell clonal
heteroresistance in an isogenic bacterial population,”Sci. Rep.,
vol. 10, pp. 1–8, 2020.
[132] J. Choi, J. Yoo, M. Lee, et al., “A rapid antimicrobial susceptibility
test based on single-cell morphological analysis,” Sci. Transl.
Med., vol. 6, p. 267ra174, 2014.
[133] B. Li, Y. Qiu, A. Glidle, et al., “Gradient microfluidics enables
rapid bacterial growth inhibition testing,” Anal. Chem., vol. 86,
pp. 3131–3137, 2014.
[134] Ö. Baltekin, A. Boucharin, E. Tano, D. I. Andersson, and J. Elf,
“Antibiotic susceptibility testing in less than 30 min using
direct single-cell imaging,” Proc. Natl. Acad. Sci. U. S. A., vol.
114, pp. 9170–9175, 2017.
[135] S. Kasas, F. S. Ruggeri, C. Benadiba, et al., “Detecting
nanoscale vibrations as signature of life,” Proc. Natl. Acad. Sci.
U. S. A., vol. 112, pp. 378–381, 2015.
[136] M. Mallén-Alberdi, N. Vigués, J. Mas, C. Fernández-Sánchez,
and A. Baldi, “Impedance spectral fingerprint of E. coli cells on
interdigitated electrodes: a new approach for label free and
selective detection,” Sens. Bio-Sensing Res., vol. 7,
pp. 100–106, 2016.
[137] A. Rohani, J. H.Moore, Y. H. Su, V. Stagnaro, C.Warren, andN. S.
Swami, “Single-cell electro-phenotyping for rapid assessment
of Clostridium difficile heterogeneity under vancomycin
treatment at sub-MIC (minimum inhibitory concentration)
levels,” Sensors Actuators B Chem, vol. 276, pp. 472–480,
2018.
[138] Y. Yang, K. Gupta, and K. L. Ekinci, “All-electrical monitoring of
bacterial antibiotic susceptibility in a microfluidic device,” Proc.
Natl. Acad. Sci. U. S. A., vol. 117, no. 20, pp. 10639–10644, 2020.
[139] D. Cialla-May, X. S. Zheng, K. Weber, and J. Popp, “Recent
progress in surface-enhanced Raman spectroscopy for
biological and biomedical applications: from cells to clinics,”
Chem. Soc. Rev., vol. 46, pp. 3945–3961, 2017.
[140] B. Lorenz, C. Wichmann, S. Stöckel, P. Rösch, and J. Popp,
“Cultivation-free Raman spectroscopic investigations of
bacteria,” Trends Microbiol., vol. 25, pp. 413–424, 2017.
[141] A. Tannert, R. Grohs, J. Popp, and U. Neugebauer,
“Phenotypic antibiotic susceptibility testing of pathogenic
bacteria using photonic readout methods: recent
achievements and impact,” Appl. Microbiol. Biotechnol.,
vol. 103, pp. 549–566, 2019.
[142] V. O. Baron, M. Chen, B. Hammarstrom, et al., “Real-time
monitoring of live mycobacteria with a microfluidic acoustic-
Raman platform,” Commun. Biol., vol. 3, pp. 1–8, 2020.
[143] W. Adamus-Białek, Ł. Lechowicz, A. B. Kubiak-Szeligowska, M.
Wawszczak, E. Kamińska, and M. Chrapek, “A new look at the
drug-resistance investigation of uropathogenic E. coli strains,”
Mol. Biol. Rep., vol. 44, pp. 191–202, 2017.
[144] A. Salman, U. Sharaha, E. Rodriguez-Diaz, et al., “Detection of
antibiotic resistant: Escherichia coli bacteria using infrared
microscopy and advanced multivariate analysis,” Analyst, vol.
142, pp. 2136–2144, 2017.
[145] M. Drancourt, A. Michel-Lepage, S. Boyer, and D. Raoult, “The
point-of-care laboratory in clinical microbiology,” Clin.
Microbiol. Rev., vol. 29, pp. 429–447, 2016.
G. Pitruzzello et al.: Nanophotonics for bacteria 4471
[146] O. Pashchenko, T. Shelby, T. Banerjee, and S. Santra, “A
comparison of optical, electrochemical, magnetic, and
colorimetric point-of-care biosensors for infectious
disease diagnosis,” ACS Infect. Dis., vol. 4, pp. 1162–1178,
2018.
[147] M. R. Pulido, M. García-Quintanilla, R. Martín-Peña,
J. M. Cisneros, and M. J. McConnell, “Progress on the
development of rapid methods for antimicrobial susceptibility
testing,” J. Antimicrob. Chemother., vol. 68, pp. 2710–2717,
2013.
[148] A. Drayton, K. Li, M. Simmons, C. Reardon, and T. Krauss,
“Performance limitations of resonant refractive index sensors
with low-cost components,” Under Review, https://doi.org/10.
1364/OE.400236.
4472 G. Pitruzzello et al.: Nanophotonics for bacteria
